ScholarLens Back to search
2021•BMJRequires access

Covid-19: Booster doses to be offered to 30 million people in UK

Jacqui Wise

Open publisher page 18 citations

Abstract

Covid-19: Booster doses to be offered to 30 million people in UK Jacqui WiseBooster doses of a covid-19 vaccine are to be offered to the highest risk groups in the UK as a result of new advice from the Joint Committee on Vaccination and Immunisation.A booster dose will be offered to all people who were vaccinated during phase 1 of the vaccine programme, no earlier than six months after they received their second dose.The JCVI advises a preference for the Pfizer-BioNTech vaccine regardless of which vaccine someone had for their primary doses.This follows data from the Cov-boost trial that indicated that this vaccine is well tolerated as a third dose and provides a strong booster response.1

About this research paper

What this paper is about

Covid-19: Booster doses to be offered to 30 million people in UK Jacqui WiseBooster doses of a covid-19 vaccine are to be offered to the highest risk groups in the UK as a result of new advice from the Joint Committee on Vaccination and Immunisation.A booster dose will be offered to all people who were vaccinated during phase 1 of the vaccine programme, no earlier than six months after they received their second dose.The JCVI advises a preference for the Pfizer-BioNTech vaccine regardless of which vaccine someone had for their primary doses.This follows data from the Cov-boost trial that indicated that this vaccine is well tolerated as a third dose and provides a strong booster response.1

Why it matters

OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Covid-19: Booster doses to be offered to 30 million people in UK Jacqui WiseBooster doses of a covid-19 vaccine are to be offered to the highest risk groups in the UK as a result of new advice from the Joint Committee on Vaccination and Immunisation.A booster dose will be offered to all people who were vaccinated during phase 1 of the vaccine programme, no earlier than six months after they received their second dose.The JCVI advises a preference for the Pfizer-BioNTech vaccine regardless of which vaccine someone had for their primary doses.This follows data from the Cov-boost trial that indicated that this vaccine is well tolerated as a third dose and provides a strong booster response.1

Key concepts: Booster (rocketry), Booster dose, Coronavirus disease 2019 (COVID-19), Vaccination, Medicine, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 2019-20 coronavirus outbreak, Family medicine

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Covid-19: Booster doses to be offered to 30 million people in UK — Research Paper | ScholarLens